Trump is using the threat of tariffs to encourage domestic manufacturing by pressuring pharma companies and leveraging the reliance on Indian and Chinese APIs.
2 reports, 2 independent
Updated Jul 1
Gone quiet
- Reports
- 2
- Developments
- 5
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump is using the threat of tariffs to encourage domestic manufacturing by pressuring pharma companies and leveraging the reliance on Indian and Chinese APIs.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- An unnamed policy system has implemented preferential treatment for foreign API imports.Sub-event
- Eli Lilly and Company announced that its operations will expand in the Cincinnati region, partnering with Resilience, amid Trump administration's tariff policies.Sub-event
- The Indian Pharmaceutical Alliance announced a tariff policy for generic imports, affirming its status as a trusted partner for US healthcare.Sub-event
Trump proposes US tariffs on generic drugs, targeting Indian pharmaceutical reliance.1 source
Trump threatens tariffs to push pharma companies like Eli Lilly toward domestic manufacturing.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Donald Trump announced potential tariffs on goods imported from India.
- Trump proposes tariffs on countries buying Russian oil and gas, while Fed policy affects global sentiment.
- The Institute for Supply Management noted on August 8, 2025, that tariffs from the Trump administration were causing market volatility and hurting industry and consumers.
- Trump imposed arbitrary tariffs and threatened India.
- Global tariffs from Donald Trump began on August 4, 2025, impacting international markets and financial news services like Bloomberg L.P.
Coverage
Newest first; wire copies grouped- indiatimes.com
- ZacksPharma Companies Remain Calm Amid Fresh Tariff Threat by Trump And the tariff threat is back. President Trump has once again threatened to impose heavy tariffs on pharmaceutical imports that will pos